Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Celixir Limited

http://www.celixir.com/

Latest From Celixir Limited

Deals Shaping The Medical Industry, June 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in May 2016.

BioPharmaceutical Medical Device

Favorable Japan Environment Nurtures Daiichi/CTL Cell Therapy Deal

Daiichi Sankyo's recent deal for Japan rights to a cell therapy agent illustrates the ongoing corporate appetite for assets able to benefit from the country's favorable regulatory framework for such products.

BioPharmaceutical Asia Pacific
See All

Company Information

  • Industry
  • Biotechnology
  • Other Names / Subsidiaries
    • Cell Therapy Limited
    • Cell Therapy, Ltd.
UsernamePublicRestriction

Register